| |
Men
(n=153) |
Women
(n=48) |
P value |
Age<60
(n=75) |
Age≥60
(n=126) |
P value |
| Positive patientsa |
|
|
|
|
|
|
| IFOBT |
67(43.8) |
19(39.6) |
0.607 |
28(37.3) |
58(46.0) |
0.228 |
| TF |
64(41.8) |
29(60.4) |
0.024 |
37(49.3) |
56(44.4) |
0.501 |
| BOTH |
32(20.9) |
17(35.4) |
0.041 |
19(25.3) |
30(23.8) |
0.808 |
| EITHER |
99(64.7) |
31(64.6) |
0.988 |
46(61.3) |
84(66.7) |
0.444 |
| Sensitivityb |
|
|
|
|
|
|
| All advanced adenomas and cancer |
|
|
|
|
|
|
| Total |
51 |
17 |
|
24 |
44 |
|
| IFOBT |
30(58.8) |
8(47.1) |
0.398 |
12(50.0) |
26(59.1) |
0.471 |
| TF |
30(58.8) |
10(58.8) |
0.776 |
16(66.7) |
24(54.5) |
0.332 |
| BOTH |
19(37.3) |
6(35.3) |
0.885 |
10(41.7) |
15(34.1) |
0.536 |
| EITHER |
41(80.4) |
12(70.6) |
0.398 |
18(75.0) |
35(79.5) |
0.666 |
| Cancer |
|
|
|
|
|
|
| Total |
13 |
8 |
|
11 |
10 |
|
| IFOBT |
9(69.2) |
3(37.5) |
0.154 |
7(63.6) |
5(50.0) |
0.528 |
| TF |
10(76.9) |
6(75.0) |
0.920 |
8(72.7) |
8(80.0) |
0.696 |
| BOTH |
7(53.8) |
3(37.5) |
0.466 |
6(54.5) |
4(40.0) |
0.505 |
| EITHER |
12(92.3) |
6(75.0) |
0.271 |
9(81.8) |
9(90.0) |
0.593 |
aNumbers in parenthesis are the rates calculated by number of positive patients divided by the number of total patients per group.
bSensitivity is the number of true positives relative to the number of persons with lesions. |